William Blair Investment Management, LLC Krystal Biotech, Inc. Transaction History
William Blair Investment Management, LLC
- $34.7 Billion
- Q2 2025
A detailed history of William Blair Investment Management, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, William Blair Investment Management, LLC holds 91,099 shares of KRYS stock, worth $17.2 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
91,099Holding current value
$17.2 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
317Shares Held
24.7MCall Options Held
418KPut Options Held
485K-
Black Rock Inc. New York, NY3.95MShares$743 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$532 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.66MShares$501 Million6.67% of portfolio
-
State Street Corp Boston, MA1.36MShares$255 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA942KShares$177 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.83B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...